Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...

As the demand for precision and efficiency in genetic research continues to grow, Creative Biogene's CRISPR library screening service stands out, allowing scientists to quickly identify and analyze ...

Duchenne Muscular Dystrophy: diagnosis, clinical development and global researchMuscular dystrophy refers to a group of rare, genetic, progressive diseases that primarily affect the body’s muscles, ...

The Synthetic Biology Market is valued at USD 16.94 Billion in 2024 and is expected to reach USD 167.98 Billion by 2035 at a ...

Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

In a significant nod to local innovation, President Yoweri Museveni has applauded Dr. Matthias Magoola, founder of Dei ...